Decheng Capital as of March 31, 2024
Portfolio Holdings for Decheng Capital
Decheng Capital holds 22 positions in its portfolio as reported in the March 2024 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Alpine Immune Sciences | 44.2 | $330M | 8.3M | 39.64 | |
| Cg Oncology (CGON) | 32.1 | $240M | 5.5M | 43.90 | |
| Zentalis Pharmaceuticals (ZNTL) | 4.4 | $33M | 2.1M | 15.76 | |
| Illumina (ILMN) | 2.4 | $18M | 129k | 137.32 | |
| BeyondSpring SHS (BYSI) | 2.4 | $18M | 5.0M | 3.57 | |
| Arcus Biosciences Incorporated (RCUS) | 2.2 | $16M | 870k | 18.88 | |
| Krystal Biotech (KRYS) | 1.6 | $12M | 66k | 177.93 | |
| 4d Molecular Therapeutics In (FDMT) | 1.5 | $11M | 348k | 31.86 | |
| Equillium (EQ) | 1.4 | $10M | 4.4M | 2.31 | |
| Phathom Pharmaceuticals (PHAT) | 1.2 | $9.0M | 850k | 10.62 | |
| Helix Acquisition Corp | 1.1 | $8.4M | 167k | 50.23 | |
| Crinetics Pharmaceuticals In (CRNX) | 1.0 | $7.4M | 158k | 46.81 | |
| 10x Genomics Cl A Com (TXG) | 1.0 | $7.3M | 196k | 37.53 | |
| Cytokinetics (CYTK) | 0.9 | $6.6M | 94k | 70.11 | |
| Legend Biotech Corp- Adr (LEGN) | 0.6 | $4.8M | 86k | 56.09 | |
| Merus N V (MRUS) | 0.6 | $4.6M | 102k | 45.03 | |
| Aura Biosciences (AURA) | 0.5 | $4.0M | 516k | 7.85 | |
| Cue Health (HLTHQ) | 0.2 | $1.7M | 9.0M | 0.19 | |
| Pyxis Oncology (PYXS) | 0.2 | $1.4M | 327k | 4.26 | |
| Aadi Bioscience (AADI) | 0.2 | $1.2M | 526k | 2.34 | |
| GeneDx Holdings Corp. Com Cl A (WGS) | 0.1 | $946k | 104k | 9.13 | |
| AtriCure (ATRC) | 0.1 | $815k | 27k | 30.42 |
